Schedule 13G ownership disclosure

China SXT Pharmaceuticals, Inc.

Security class unavailable · CUSIP: G2161P108

Event date: 2019-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,742,139
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001393825-20-000087
Form type
SC 13G
Filer
China SXT Pharmaceuticals, Inc.
CIK
CIK 1723980
Filed
Feb 07, 2020
Reporting period
Dec 31, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub